Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 4, 2009

Follicular Helper T Cells Regulated by the T-Cell Antigen Receptor Binding

  • Scientists from the Scripps Research Institute have discovered what governs the quality and quantity of follicular helper T cells (TFH), which regulate antibody responses and long-term immune protection.

    Using mouse models of protein vaccination, the researchers selected adjuvants that drive the greatest TFH-cell response. They showed that the helper T cells with the strongest binding receptor for the foreign protein antigen preferentially became the specialized TFH cells. It is these TFH cells that regulate B cells, antibody class, and affinity.

    “It looks as if the strength of that initial contact is driving cell fate,” says Michael McHeyzer-Williams, Ph.D., professor at the Scripps Research Institute. “If the helper T cells have a strong receptor for the antigen the first time they encounter it, they are much more likely to become TFH cells. More TFH cells likely means more B cells, which is the desired result.”

    The team defined three transcription factor T-bet–expressing antigen-specific effector helper T cell subsets with distinguishable function, migratory properties, and developmental programming in vivo.

    The study appeared in the March 1 online issue of Nature Immunology.

Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »